Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain
| Autor: | Colomer, R. *, Llombart-Cussac, A., Lluch, A., Barnadas, A., Ojeda, B., Carañana, V., Fernández, Y., García-Conde, J., Alonso, S., Montero, S., Hornedo, J., Guillem, V. |
|---|---|
| Zdroj: | In Annals of Oncology February 2004 15(2):201-206 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|